Outsourced Pharma App Notes & Case Studies

1. Innovative ASD Technology Improves Abandoned Cancer Medication 3/1/2024

   Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.

2. Overcoming HCP Co-Elution Issues Using Cell Line Engineering 5/15/2024

   Product quality assessments revealed that a customer’s therapeutic protein had a range of hydrophobic HCPs. Review a solution that took an alternative approach by utilizing cell line engineering.

3. 5 Must-Haves For Electronic Batch Records In Pharma Manufacturing 6/17/2025

   Pharma companies still relying on paper-based manufacturing are falling behind. Discover how digital transformation boosts efficiency, reduces errors, and ensures compliance in this essential shift toward smarter operations.

4. Cancer Therapeutic Drug Developer Minimizes Production Losses 1/8/2024

   Follow the journey of a prominent cancer therapeutics developer who faced persistent manufacturing challenges with liquid-filled capsules, and how they overcame product and monetary losses.

5. Mobius® ADC Reactor Performance 10/22/2024

   Learn about a family of single-use ADC reactors that has been developed to offer a safer and more efficient ADC production method than traditional mixing systems and meet the industry's growing needs.

6. A Pre-Clinical Study For Diet-Induced Obesity 3/28/2025

   Here, we look at the importance of using high-fat diet-induced obesity models to evaluate and compare the efficacy of anti-obesity and anti-diabetic treatments like rimonabant and liraglutide.

7. Injection Site Reaction Screening Methodology 6/6/2025

   Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.

8. Production Of A Highly Concentrated Monoclonal Antibody 10/4/2024

   The production of a highly concentrated monoclonal antibody requires many process steps. Discover how to achieve a final mAb concentration above 200 g/L while maintaining critical quality attributes.

9. Transforming A Liquid Protein Solution Into A Solid Oral Dosage Form 3/4/2025

   Unlocking the potential of oral protein therapeutics requires innovative formulation and manufacturing strategies to overcome stability, absorption, and bioavailability challenges.

10. Flow Chemistry Experiments Of Highly Hazardous Butyl Lithium Reactions 5/22/2025

    By adopting flow chemistry for a production platform that reduces utility costs and solvent consumption, researchers can overcome the risks and challenges of Butyl Lithium chemistry.